WuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year

Reuters

05-19

WuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year

WuXi Biologics (Cayman) Inc., a global Contract Research, Development, and Manufacturing Organization (CRDMO), announced its inclusion in the 2025 S&P Global Sustainability Yearbook (China Edition) for the third consecutive year. The announcement was made at the S&P Global Sustainable1 forum in Shenzhen on May 13, 2025. WuXi Biologics achieved a Corporate Sustainability Assessment $(CSA)$ score ranking in the top 1%, securing its place in both the Global Sustainability Yearbook and the China Edition. The Sustainability Yearbook recognizes companies excelling in corporate sustainability within their industries. WuXi Biologics' CEO and Chairman of the ESG Committee, Dr. Chris Chen, stated that the inclusion reflects the company's continued commitment to enhancing sustainability performance and promoting responsible practices throughout the value chain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2536506081"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2536506081\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2536506081?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-19 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2536506081","market":"nz","top_or_hot":-1,"title":"WuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      WuXi Biologics Earns Top 1% Ranking in S&amp;P Global Sustainability Yearbook for Third Year\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        WuXi Biologics (Cayman) Inc., a global Contract Research, Development, and Manufacturing Organization (CRDMO), announced its inclusion in the 2025 S&amp;P Global Sustainability Yearbook (China Edition) for the third consecutive year. The announcement was made at the S&amp;P Global Sustainable1 forum in Shenzhen on May 13, 2025. WuXi Biologics achieved a Corporate Sustainability Assessment <a href=\"https://laohu8.com/S/CSA\">$(CSA)$</a> score ranking in the top 1%, securing its place in both the Global Sustainability Yearbook and the China Edition. The Sustainability Yearbook recognizes companies excelling in corporate sustainability within their industries. WuXi Biologics' CEO and Chairman of the ESG Committee, Dr. Chris Chen, stated that the inclusion reflects the company's continued commitment to enhancing sustainability performance and promoting responsible practices throughout the value chain.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/WXIBF\">Wuxi Biologics (Cayman) Inc</a>. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-19 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      WuXi Biologics Earns Top 1% Ranking in S&amp;P Global Sustainability Yearbook for Third Year\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        WuXi Biologics (Cayman) Inc., a global Contract Research, Development, and Manufacturing Organization (CRDMO), announced its inclusion in the 2025 S&amp;P Global Sustainability Yearbook (China Edition) for the third consecutive year. The announcement was made at the S&amp;P Global Sustainable1 forum in Shenzhen on May 13, 2025. WuXi Biologics achieved a Corporate Sustainability Assessment <a href=\"https://laohu8.com/S/CSA\">$(CSA)$</a> score ranking in the top 1%, securing its place in both the Global Sustainability Yearbook and the China Edition. The Sustainability Yearbook recognizes companies excelling in corporate sustainability within their industries. WuXi Biologics' CEO and Chairman of the ESG Committee, Dr. Chris Chen, stated that the inclusion reflects the company's continued commitment to enhancing sustainability performance and promoting responsible practices throughout the value chain.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/WXIBF\">Wuxi Biologics (Cayman) Inc</a>. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL4Wb5n1:1","article_id":"2536506081","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2536506081","pubTimestamp":1747645363,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"WuXi Biologics  Inc., a global Contract Research, Development, and Manufacturing Organization , announced its inclusion in the 2025 S&P Global Sustainability Yearbook  for the third consecutive year. The announcement was made at the S&P Global Sustainable1 forum in Shenzhen on May 13, 2025. WuXi Biologics achieved a Corporate Sustainability Assessment  score ranking in the top 1%, securing its place in both the Global Sustainability Yearbook and the China Edition. The Sustainability Yearbook recognizes companies excelling in corporate sustainability within their industries. WuXi Biologics' CEO and Chairman of the ESG Committee, Dr. Chris Chen, stated that the inclusion reflects the company's continued commitment to enhancing sustainability performance and promoting responsible practices throughout the value chain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"药明生物连续第三年在标普全球可持续发展年鉴中排名前1%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":0.9},"content_text":"WuXi Biologics Earns Top 1% Ranking in S&P Global Sustainability Yearbook for Third Year\n    \n\n        WuXi Biologics (Cayman) Inc., a global Contract Research, Development, and Manufacturing Organization (CRDMO), announced its inclusion in the 2025 S&P Global Sustainability Yearbook (China Edition) for the third consecutive year. The announcement was made at the S&P Global Sustainable1 forum in Shenzhen on May 13, 2025. WuXi Biologics achieved a Corporate Sustainability Assessment $(CSA)$ score ranking in the top 1%, securing its place in both the Global Sustainability Yearbook and the China Edition. The Sustainability Yearbook recognizes companies excelling in corporate sustainability within their industries. WuXi Biologics' CEO and Chairman of the ESG Committee, Dr. Chris Chen, stated that the inclusion reflects the company's continued commitment to enhancing sustainability performance and promoting responsible practices throughout the value chain.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}